AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Sinovac Biotech Ltd. Has Received Over US $1 Million in Government Research Funding for SARS Vaccine.

Business Wire

| June 01, 2004 | COPYRIGHT 2004 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Business Editors/Health/Medical Writers

BEIJING--(BUSINESS WIRE)--June 1, 2004

Sinovac Biotech Ltd. ("Sinovac") (OTCBB:SNVBF) is pleased to announce that to date, Sinovac has received more than US $1 million in research funding from the Chinese state government for its inactivated SARS vaccine development program. It is expected that funding of Sinovac's SARS vaccine development program will continue to be partially supported by the Chinese government. Management of Sinovac believes that because of its low-cost advantage in China, this amount would fund significantly more R & D in China than the same research budget in the United States.

Sinovac is the only company in China, and indeed the world, to have been approved to conduct human clinical trials of a SARS vaccine.

The Chinese State Drug Administration, the SFDA, has stated that it is fast-tracking the drug approval process for Sinovac's potential SARS vaccine. Based on the regular drug approval process in China, it would take between 3 to 5 years for a SARS vaccine to receive final commercial approval. However, with fast-tracking the process, it could take as little as 1 to 2 years. Furthermore, it is still possible for the SARS vaccine to be urgently approved for use in the event of further SARS outbreaks. An urgently expedited Chinese inoculation program would first target the following groups: 1) the more than 5.2 million medical workers all over China; and 2) the population in a particular outbreak area, such as Beijing (about 13.8 million people), Guangdong Province (about 86.4 million people), or Hong Kong (about 6.71 million people).

The ultimate aim of the vaccine will be to provoke the body's immune system into action, so that it can destroy the SARS virus if infected.

The recent confirmation of six new SARS cases in China underscores the need to develop an effective vaccine in quantity. China's health ministry traced all infections back to a research laboratory at the Institute of Virology in Beijing, where the Chinese Centre for Disease Control was conducting SARS research. In the wake of the discovery, world health authorities sent teams of experts to China to investigate the outbreak. These authorities concluded that the epidemic did not pose a public health danger. The reaction to this recent outbreak serves to remind us that the impact of a new SARS threat is global in scope. A new, widespread SARS outbreak would likely have a devastating ...

Related articles from newspapers, magazines, journals, and more
Sinovac Biotech Ltd. Has Received a Further US $1.2 Million in Government...
Press release article from: Business Wire July 20, 2004 700+ words
...support for Sinovac's SARS vaccine program to US $2...funding of Sinovac's SARS vaccine development program...be required in the United States or Europe to conduct...Sinovac's potential SARS vaccine. Based on the regular...
Sinovac Biotech Ltd. Releases Further Results From SARS Vaccine Phase I Human...
Press release article from: Business Wire December 13, 2004 700+ words
...development of Sinovac's SARS vaccine. The ultimate aim...clinical trials of a SARS vaccine. Clinical Trial Design...regulated by the FDA in the United States. The process involves...process for Sinovac's SARS vaccine. Pre-clinical trials...
Sinovac Biotech Ltd.: To Commence Phase I Clinical Testing of SARS Vaccine.
Press release article from: Business Wire February 5, 2004 700+ words
...s potential SARS vaccine have been developed...the FDA in the United States. The process...s potential SARS vaccine. According to...China to test SARS vaccine on humans...SECTION 27A OF THE UNITED STATES SECURITIES ACT...
Sinovac Biotech Ltd. Updates on Recent Meetings With The World Health...
Press release article from: Business Wire April 30, 2004 700+ words
...commencement of clinical trials for its SARS vaccine has been ratified by members of...a meeting - "Review of Chinese SARS Vaccine Protocol" - to discuss the Phase I Clinical Trial for inactivated SARS vaccine developed by Sinovac. The purpose...
China soon to start clinical trial of SARS vaccine.
News wire article from: Asia Africa Intelligence Wire March 9, 2004 700+ words
...worldwide standard for SARS vaccine experiments, Roy Wadia...clinical test of the SARS vaccine in February this year...developed by Canada and the United States will go into clinical...clinical trials on a SARS vaccine are under way in China...
Sinovac Biotech Ltd.: Update on Human Clinical Trials of SARS Vaccine;...
Press release article from: Business Wire July 8, 2004 700+ words
...volunteers in Phase 1 clinical trials of its SARS vaccine received their first inoculation two...performed worldwide in the development of a SARS vaccine. The vaccination and observation of...by Sinovac will help determine if its SARS vaccine is a safe anti-viral antigen for the...
Sinovac Biotech Ltd. Conducts World's First Human Clinical Testing of SARS...
Press release article from: Business Wire May 25, 2004 700+ words
...the first day of the SARS vaccine clinical testing...clinical trials of a SARS vaccine. Clinical Trial Design...regulated by the FDA in the United States. The process involves...Sinovac's potential SARS vaccine. As previously announced...
Sinovac Biotech Ltd. Updates on Phase I Human Clinical Testing of SARS Vaccine.
Press release article from: Business Wire September 7, 2004 700+ words
...for its inactivated SARS vaccine have now been vaccinated...two doses of either SARS vaccine or placebo. The immunization...regulated by the FDA in the United States. The process involves...Sinovac's potential SARS vaccine. Pre-clinical trials...
SARS vaccine phase I clinical testing commences.
Newspaper article from: Pharma Business Week March 1, 2004 700+ words
...clinical trials of a SARS vaccine. The first phase of...Sinovac's potential SARS vaccine have been developed...Administration in the United States. The process involves...Sinovac's potential SARS vaccine. According to the...
Sinovac Biotech Ltd. Updates on Phase I Human Clinical Testing of SARS...
Press release article from: Business Wire July 19, 2004 700+ words
...volunteers with high-dosage of its SARS vaccine started on July 15th, 2004. The 6...high-dosage (32 su/mL antigen) SARS vaccine or a placebo. After a 72-hour observation...low-dosage (16 su/mL antigen) SARS vaccine are all in good health condition. There...
For more facts and information, see all results

Source: HighBeam Research, Sinovac Biotech Ltd. Has Received Over US $1 Million in Government...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA